Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission

The engineered protein eCD4Ig has emerged as a promising approach to achieve HIV remission in the absence of antiviral therapy. eCD4Ig neutralizes nearly all HIV-1 isolates and induces antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro. To characterize the in vivo antiviral neutralization...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Ashish, Gardner, Matthew, Mayer, Bryan T., Jerome, Keith R., Farzan, Michael, Schiffer, Joshua T., Cardozo-Ojeda, E. Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754410/
https://www.ncbi.nlm.nih.gov/pubmed/35020436
http://dx.doi.org/10.1126/sciadv.abj5666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754410/
https://www.ncbi.nlm.nih.gov/pubmed/35020436
http://dx.doi.org/10.1126/sciadv.abj5666

Ejemplares similares